News und Analysen
Exelixis Q2 Revenue Falls 11 Percent
Exelixis (NASDAQ:EXEL), an oncology-focused biotech, reported results for Q2 2025 on July 28, 2025. For the period, the company delivered non-GAAP earnings per share (EPS) of $0.75 in Q2 FY2025
Boston Sci Q2 Revenue Up 23%
Boston Scientific (NYSE:BSX), a leading medical device maker known for its heart and surgical products, released second-quarter results on July 23, 2025. Revenue reached $5.06 billion for Q2 2025
2 Top Dividend Stocks to Buy Right Now and Hold Forever
Over the long run, dividends can make a significant difference in your returns, whether you choose to reinvest the payouts or retain the cash for other purposes. However, many companies that offer
The 3 Things That Matter for Vertex Pharmaceuticals Now
Vertex Pharmaceuticals (NASDAQ: VRTX) has been a terrific stock to own over the past decade. The stock has outperformed the market over this period, thanks to consistent financial results and
3 Surprisingly Underrated Stocks to Buy Right Now
You'd think that companies with long, successful track records and market caps in the hundreds of billions of dollars would be viewed as relatively formidable. However, that's not always the case.
Better Dividend Stock: Alphabet vs. AT&T
Investors looking to grow their passive income stream with dividend stocks have two basic options. Dividend payers that raise their payouts rapidly tend to offer low yields up front, while
AT&T Shares Have Sunk Despite a Subscriber Surge. Time to Buy the Dip?
AT&T (NYSE: T) has quietly been a great-performing stock over the past couple of years, but it has pulled back after the company failed to raise its guidance when it reported its second quarter
2 Healthcare Stocks That Are Losing to the S&P 500 This Year
Even with all the volatility and the flirting with bear-market territory, the S&P 500 index is well in the green this year, up about 8% since early January. Some stocks haven't been so lucky
Pacific Premier Posts Q2 Profit Drop
Pacific Premier Bancorp (NASDAQ:PPBI), a commercial bank focused on business and specialty lending across the western United States, released its Q2 2025 financial results on July 24, 2025. The
Should You Buy UnitedHealth Before July 29?
In this video, I will talk about UnitedHealth Group (NYSE: UNH) and why buying the stock before it reports earnings could make sense. Watch the short video to learn more, consider subscribing, and
Helix Energy Q2 Revenue Falls 17%
Helix Energy Solutions Group (NYSE:HLX), a diversified offshore energy services provider, reported weaker-than-expected Q2 2025 results, released on July 23, 2025. The headline was a disappointing
Earnings Summary on Patterson-UTI Energy
Patterson-UTI Energy (NASDAQ:PTEN), a large oilfield services provider focused on drilling and completion operations across North America, reported financial results for Q2 2025 on July 23, 2025
New Horizon Aircraft Stock Soars 196%, Insider Sells 50,000 Shares
On July 10, 2025, Stewart Murray Lee (Head of People & Strategy) executed an open market sale of 50,000 shares of New Horizon Aircraft Ltd.(NASDAQ:HOVR), with the transaction disclosed in a Form 4
FirstService FSV Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, July 24, 2025 at 11 a.m. ET
Chief Executive Officer — Scott Patterson
Source Fool.com
Novocure: Steady Ahead of Key Milestones
Here's our initial take on Novocure's (NASDAQ: NVCR) fiscal 2025 second-quarter financial report.
Novocure reported no surprises in its latest quarter, with revenue up 6% for the year and both
The 3 Things That Matter for AbbVie Now
It's been a challenging past three years for AbbVie (NYSE: ABBV). The pharmaceutical leader lost U.S. patent exclusivity for its top-selling medicine, Humira, and encountered a significant clinical
Is This Stock a Buy After Soaring by 20% in 1 Day?
It's been a rough year for Sarepta Therapeutics (NASDAQ: SRPT), a small-cap biotech that develops medicines for rare diseases. The company's shares are down by 88% year to date due to safety issues
Viking Therapeutics Posts Wider Q2 Loss
Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on treatments for obesity and metabolic diseases, released results for its second quarter on July 23, 2025. The
Why AT&T Stock Bumped Higher Today
AT&T (NYSE: T) released its latest set of quarterly results Wednesday morning. While these weren't strong enough to bring the bulls charging into the stock, they were nevertheless pleasing for
AT&T Posts 6 Percent EPS Gain in Q2
AT&T (NYSE:T), a U.S. telecommunications and connectivity provider, released its Q2 2025 earnings on July 23, 2025. The company posted adjusted earnings per share of $0.54, just above the average
Boston Sci Q2 Revenue Up 23 Percent
Boston Scientific (NYSE:BSX), a leader in medical devices for cardiovascular and surgical markets, reported its second-quarter 2025 results on July 23, 2025. The company posted revenue and earnings
First Horizon Posts Q2 EPS Beat
First Horizon (NYSE:FHN), a regional banking group focused on retail and commercial lending in the Southeast, released its second quarter 2025 earnings on July 16, 2025. The most important news was
AT&T Posts 3.5% Revenue Gain in Q2
AT&T (NYSE:T), a major U.S. telecommunications company known for wireless and fiber broadband services, released its second-quarter 2025 results on July 23, 2025. The company reported revenue of
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
There are no guarantees on Wall Street, especially when it comes to dividends. The board of directors of each company decides on the dividend in private. But income investors can glean some
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.
What makes a good dividend stock? The answer depends a bit on who's looking, of course. But there are some general themes that can be drawn out by looking at Johnson & Johnson (NYSE: JNJ) and


